iCAD to Participate at the Imagine AI + Healthcare Investor Summit
NASHUA, N.H., Dec. 6, 2021 -- iCAD, a leader in cancer detection and therapy solutions, announced that Stacey Stevens, President and incoming CEO, will present at Oppenheimer’s Imagine AI + Healthcare Investor Summit. The presentation is scheduled for December 7, 2021, from 11:00 a.m. to 11:20 a.m. ET. This event, organized by Oppenheimer in collaboration with the Alliance for AI in Healthcare, highlights advancements in AI technology within healthcare.
For more information, visit www.icadmed.com.
- None.
- None.
NASHUA, N.H., Dec. 06, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey Stevens, President and incoming Chief Executive Officer, will present a corporate overview at Oppenheimer’s Imagine AI + Healthcare Investor Summit being hosted by Oppenheimer in partnership with the Alliance for AI in Healthcare (AAIH).
Oppenheimer’s Imagine AI + Healthcare Investor Summit
Date: Tuesday, December 7th
Time: 11:00 a.m. to 11:20 a.m. ET
Registration Link
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Relations:
Brian Ritchie, LifeSci Advisors
+ 1-212-915-2578
britchie@lifesciadvisors.com
FAQ
What is iCAD's presentation time at Oppenheimer’s Imagine AI + Healthcare Investor Summit?
Who is presenting at the Oppenheimer Investor Summit for iCAD?
What is Oppenheimer’s Imagine AI + Healthcare Investor Summit about?
Where is iCAD located?
What does iCAD specialize in?
